Antibody-Drug Conjugates (ADCs)
Also called ADCs. They act in these three steps:
1. Bind selectively to the malignant cell's antibody.
2. Doing this allows to enter directly into the tumorous cell.
3. Release cytotoxic molecules that kill the malignant cell.
Get the latest thought leadership on your Acute Myeloid Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.